CRIS Q3 2020 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$14M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-4.0% YoY

Gross Profit

$3M95.1% margin

Operating Income

-$5M-171.8% margin

Net Income

-$6M-217.9% margin

EPS (Diluted)

$-2.19

QoQ Revenue Growth

+16.2%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$623,000

Balance Sheet

Total Assets

$46M

Total Liabilities

$74M

Stockholders' Equity

-$29M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	-4.0%
Gross Profit	$3M	$3M	-3.8%
Operating Income	-$5M	-$5M	+11.5%
Net Income	-$6M	-$6M	+7.2%

Revenue Segments

Gross Royalty Revenue

$3M99%

Contra Revenue

$22,0001%